Clinical Application of Detecting 21-Gene Recurrence Score in Predicating Prognosis and Therapy Response of Patients with Breast Cancer from Two Medical Centers

Guodong Xiao, Jinying Meng, Jing Zhang, Gang Li, Ning Du, Sida Qin, Jichang Wang, Chongwen Xu, Hong Ren, Shou-Ching Tang, Xin Sun

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

To determine the most suitable strategy in treating patients with invasive breast cancer from Northwest China. Lower recurrence score (RS) correlated with lower recurrence ratio. Patients having a medium-high 21-gene RS who received adjuvant therapy presented lower recurrence risk. Younger patients having RS results (⩾31) tended to accept adjuvant therapy more often, however, those having intermediate RS results were inclined to wait and did not receive chemotherapy. These results suggested that RS-based precision medicine will allow individualized diagnosis and treatment, resulting in better outcomes and preserved medical resources.

Original languageEnglish (US)
Pages (from-to)639-646
Number of pages8
JournalCancer Investigation
Volume35
Issue number10
DOIs
StatePublished - Nov 26 2017

Fingerprint

Breast Neoplasms
Recurrence
Genes
Therapeutics
Precision Medicine
China
Drug Therapy

Keywords

  • 21-Gene recurrence score
  • Breast cancer
  • Cancer stem cells
  • Recurrence risk

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Clinical Application of Detecting 21-Gene Recurrence Score in Predicating Prognosis and Therapy Response of Patients with Breast Cancer from Two Medical Centers. / Xiao, Guodong; Meng, Jinying; Zhang, Jing; Li, Gang; Du, Ning; Qin, Sida; Wang, Jichang; Xu, Chongwen; Ren, Hong; Tang, Shou-Ching; Sun, Xin.

In: Cancer Investigation, Vol. 35, No. 10, 26.11.2017, p. 639-646.

Research output: Contribution to journalArticle

Xiao, Guodong ; Meng, Jinying ; Zhang, Jing ; Li, Gang ; Du, Ning ; Qin, Sida ; Wang, Jichang ; Xu, Chongwen ; Ren, Hong ; Tang, Shou-Ching ; Sun, Xin. / Clinical Application of Detecting 21-Gene Recurrence Score in Predicating Prognosis and Therapy Response of Patients with Breast Cancer from Two Medical Centers. In: Cancer Investigation. 2017 ; Vol. 35, No. 10. pp. 639-646.
@article{4e3b38089d714783a47fbdcfda7a58d0,
title = "Clinical Application of Detecting 21-Gene Recurrence Score in Predicating Prognosis and Therapy Response of Patients with Breast Cancer from Two Medical Centers",
abstract = "To determine the most suitable strategy in treating patients with invasive breast cancer from Northwest China. Lower recurrence score (RS) correlated with lower recurrence ratio. Patients having a medium-high 21-gene RS who received adjuvant therapy presented lower recurrence risk. Younger patients having RS results (⩾31) tended to accept adjuvant therapy more often, however, those having intermediate RS results were inclined to wait and did not receive chemotherapy. These results suggested that RS-based precision medicine will allow individualized diagnosis and treatment, resulting in better outcomes and preserved medical resources.",
keywords = "21-Gene recurrence score, Breast cancer, Cancer stem cells, Recurrence risk",
author = "Guodong Xiao and Jinying Meng and Jing Zhang and Gang Li and Ning Du and Sida Qin and Jichang Wang and Chongwen Xu and Hong Ren and Shou-Ching Tang and Xin Sun",
year = "2017",
month = "11",
day = "26",
doi = "10.1080/07357907.2017.1405015",
language = "English (US)",
volume = "35",
pages = "639--646",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "10",

}

TY - JOUR

T1 - Clinical Application of Detecting 21-Gene Recurrence Score in Predicating Prognosis and Therapy Response of Patients with Breast Cancer from Two Medical Centers

AU - Xiao, Guodong

AU - Meng, Jinying

AU - Zhang, Jing

AU - Li, Gang

AU - Du, Ning

AU - Qin, Sida

AU - Wang, Jichang

AU - Xu, Chongwen

AU - Ren, Hong

AU - Tang, Shou-Ching

AU - Sun, Xin

PY - 2017/11/26

Y1 - 2017/11/26

N2 - To determine the most suitable strategy in treating patients with invasive breast cancer from Northwest China. Lower recurrence score (RS) correlated with lower recurrence ratio. Patients having a medium-high 21-gene RS who received adjuvant therapy presented lower recurrence risk. Younger patients having RS results (⩾31) tended to accept adjuvant therapy more often, however, those having intermediate RS results were inclined to wait and did not receive chemotherapy. These results suggested that RS-based precision medicine will allow individualized diagnosis and treatment, resulting in better outcomes and preserved medical resources.

AB - To determine the most suitable strategy in treating patients with invasive breast cancer from Northwest China. Lower recurrence score (RS) correlated with lower recurrence ratio. Patients having a medium-high 21-gene RS who received adjuvant therapy presented lower recurrence risk. Younger patients having RS results (⩾31) tended to accept adjuvant therapy more often, however, those having intermediate RS results were inclined to wait and did not receive chemotherapy. These results suggested that RS-based precision medicine will allow individualized diagnosis and treatment, resulting in better outcomes and preserved medical resources.

KW - 21-Gene recurrence score

KW - Breast cancer

KW - Cancer stem cells

KW - Recurrence risk

UR - http://www.scopus.com/inward/record.url?scp=85038641620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038641620&partnerID=8YFLogxK

U2 - 10.1080/07357907.2017.1405015

DO - 10.1080/07357907.2017.1405015

M3 - Article

C2 - 29243989

AN - SCOPUS:85038641620

VL - 35

SP - 639

EP - 646

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 10

ER -